Merck fights back against Roche in adjuvant lung cancer therapy - - Pharmaphorum

Retrieved on: 2022-03-18 09:37:57

Tags for this article:

Click the tags to see associated articles and topics

Merck fights back against Roche in adjuvant lung cancer therapy - - Pharmaphorum. View article details on hiswai:

Excerpt

Merck prepares filings for Keytruda as adjuvant NSCLC, chasing down Roche's already approved Tecentriq with data from the KEYNOTE-091 trial that ...

Article found on: pharmaphorum.com